RETATRUTIDE: THE COMPARATIVE EXAMINATION

The novel class of GLP-1 receptor and GIP co-agonist medications, like tirzepatide, semaglutide, and the recently introduced retatrutide, represent promising advances in diabetes control. Despite all three work by influencing blood concentrations, they distinguish in their unique mechanisms of ef